Vaccine-specific T cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine
Wennerås, C.; Czerkinsky, C.; Svennerholm, A.M.
Advances in Experimental Medicine and Biology 371b: 1641-1644
1995
ISSN/ISBN: 0065-2598 PMID: 7502873 Document Number: 453466
Document emailed within 1 workday
Related Documents
Dima, V.F.; Ionescu, M.D.; Palade, R.; Balotescu, C.; Becheanu, G.; Dima, S.V. 2001: Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine Roumanian Archives of Microbiology and Immunology 60(1): 27-54Moon, H.W.; Rogers, D.G.; Rose, R. 1988: Effects of an orally administered live Escherichia coli pilus vaccine on duration of lacteal immunity to enterotoxigenic Escherichia coli in swine American Journal of Veterinary Research 49(12): 2068-2071
Domingues, C.Magda.Allan.S.; de Fátima Pereira, S.; Cunha Marreiros, A.Carolina.; Menezes, N.; Flannery, B. 2014: Introduction of sequential inactivated polio vaccine-oral polio vaccine schedule for routine infant immunization in Brazil's National Immunization Program Journal of Infectious Diseases 210 Suppl. 1: S143-S151
Miura, S. 1968: Effects of the combined administration of a triple vaccine of pertussis, diphtheria and tetanus and virus vaccine (live polio vaccine or inactivated measles vaccine) on immunity to pertussis, diphtheria and tetanus. 1. Results of the initial immunization Nihon Shonika Gakkai Zasshi. Acta Paediatrica Japonica 72(6): 767-781
Bene, M.C.; Zanin, C.; Perrin, P.; Perruchet, A.M.; Molé, C.M.; Faure, G.C. 1995: Specific antibody-producing cells in humans after oral immunization with a ribosomal vaccine Ribomunyl Advances in Experimental Medicine and Biology 371b: 1563-1566
Rudenko, L.G.; Selivanov, A.A.; Ikramov, N.V.; Tsybul'skaia, N.V.; Ostrovskiĭ, A.D. 1984: Effect of repeated immunization with inactivated influenza vaccine on the formation of specific and nonspecific immunity factors Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 12: 98-101
Svennerholm, A.M.; Holmgren, J. 1995: Oral vaccines against cholera and enterotoxigenic Escherichia coli diarrhea Advances in Experimental Medicine and Biology 371b: 1623-1628
Sartori, A.M.C.; Vicentine, M.P.; Gryninger, L.íg.C.F.; Soárez, P.C.d.; Novaes, H.M.D. 2015: Polio inactivated vaccine costs into routine childhood immunization in Brazil Revista de Saude Publica 49: 8
Kent, S.J.; Greenberg, P.D.; Hoffman, M.C.; Akridge, R.E.; McElrath, M.J. 1997: Antagonism of vaccine-induced HIV-1-specific CD4+ T cells by primary HIV-1 infection: potential mechanism of vaccine failure Journal of Immunology 158(2): 807-815
Schoub, B.D. 2012: Introduction of inactivated polio vaccine (IPV) into the routine immunization schedule of South Africa Vaccine 30 Suppl. 3: C35-C37
Barth, R.; Jaeger, O. 1970: Animal experiments with an inactivated vaccine from rabies tissue culture. I. Immunization trials in dogs and cats Berliner und Munchener Tierarztliche Wochenschrift 83(5): 81-87
Thilo, W.; Hempel, H.C.; Grimm, J.; Hayduk, J.; Starke, G. 1970: Inactivated oral Sh. sonnei vaccine. II. Formation and determination of humoral agglutinins following oral vaccination Das Deutsche Gesundheitswesen 25(6): 261-264
Dreazen, J.R. 1999: Cost of inactivated vs. oral poliovirus vaccine American Family Physician 60(7): 1929; 1932
Murphey-Corb, M.; Martin, L.N.; Davison-Fairburn, B.; Montelaro, R.C.; Miller, M.; West, M.; Ohkawa, S.; Baskin, G.B.; Zhang, J.Y.; Putney, S. 1990: A formalin inactivated whole SIV vaccine and a glycoprotein-enriched subunit vaccine confers protection against experimental challenge with pathogenic live SIV in rhesus monkeys Developments in Biological Standardization 72: 273-285
Michael-Meese, M.; Klie, H.; Schöll, W. 1980: Escherichia coli R live vaccine Suicolplex "Dessau" Archiv für Experimentelle Veterinarmedizin 34(1): 109-114
Lin, T.-Y.; Wang, Y.-H.; Chang, L.-Y.; Chiu, C.-H.; Huang, Y.-C.; Tang, H.; Bock, H.L. 2003: Safety and immunogenicity of a diphtheria, tetanus, and acellular pertussis-inactivated poliovirus vaccine/Haemophilus influenzae type B combination vaccine administered to Taiwanese infants at 2, 4, and 6 months of age Chang Gung Medical Journal 26(5): 315-322
Cheng, X.B.; Chen, T.M.; Ma, X.K.; Huang, C.F. 1989: Cloning and expression of heat-labile enterotoxin operon of an enterotoxigenic human Escherichia coli strain Chinese Journal of Biotechnology 5(1): 11-17
Townsend, J.S.; Steele, C.Brooke.; Hayes, N.; Bhatt, A.; Moore, A.R. 2017: Human Papillomavirus Vaccine as an Anticancer Vaccine: Collaborative Efforts to Promote Human Papillomavirus Vaccine in the National Comprehensive Cancer Control Program Journal of Women's Health 26(3): 200-206
Petrescu, A.L.; Cajal, N. 1984: Results obtained with the NIVGRIP inactivated influenza vaccine applicable by nasal and/or oral route Virologie 35(4): 307-314
Shahzad, A.; Köhler, G. 2009: Inactivated Polio Vaccine (IPV): a strong candidate vaccine for achieving global polio eradication program Vaccine 27(39): 5293-5294